Navigation Links
Silence Puts Comfort For Digestive Syndrome

Irritable bowel syndrome, by which 15% of Americans were suffered, was caused by distinctly personal habits and when medication doesn't help, there's often little left// to do but to suffer in silence. Others like constipation, bloating, diarrhea and gas, flatulence make their lives miserable, limiting some of their day-to-day activities.

Researches believe that the most basic of treatments is lifestyle modification instead of taking variety of drugs.

The world's largest gathering of gastrointestinal health professionals, in Los Angeles for Digestive Disease Week, where experts reported that behavior changes and dietary alterations and restrictions can help considerably to ease off the symptoms.

Cognitive behavior therapy, a brief, self-help course, in which people identify their symptoms' triggers and learn techniques to tackle conditions, such as relaxation technique and thought process methods, that modify the disease response that helped some patients in a study. Another Hypnotherapy also proved to relieve symptoms in a 12 session study for a period of one year.

Dr. Emeran Mayer, director of the UCLA Center for Neurovisceral Sciences and Women's Health reports recent theories support that irritable bowel syndrome involves a communications gap between the mind and bowel and he says we need to understand the mind-body connection.

But experts disagree on whether drugs that act on the gastrointestinal tract or psychological therapies that alter thoughts and emotions will ultimately prove most beneficial.

Jeffrey M. Lackner, an assistant professor of medicine at University at Buffalo, State University of New York, IBS affects mostly women, characterized by chronic abdominal pain and discomfort bloating, gas, constipation and diarrhea with most of the nerve endings in gut becoming sensitive to reactions lik e eating, eating special foods, strong emotions and stress.

Serotonin, which transmits impulses between brain and gut, scientists now believe that hypersensitivity is caused by its abnormal.

A potential biological explanation for the disorder has made way to the discovery of two prescription drugs, Lotronex and Zelnorm, which works on serotonin receptors.

Johanson said, Lotronex was withdrawn from the market due to causation of life-threatening ischemic colitis. Both the drugs were relabeled in 2004 to warn of a rare, serious side effect involving low blood pressure.

IBS patients whose primary symptom is constipation, can take lubiprostone (Amitiza), which was approved in January for the treatment of chronic constipation in adults.

Dr. Robert Sandler, vice president of the American said it's hard to find therapists who offer it for IBS, which works better but it is expensive and time-consuming.

Lackner selected 59 patients randomly to receive a 10-week government-sponsored behavior study, a clinic-based behavioral treatment. Here people learn how to cope with behavior disabilities by adopting muscle relaxation exercises, avoid worrying in public.

In people, who undertook therapy 74% improved in the 10-week program but only 73% improved in the quicker and less costly, four-session program. A persisted beneficial state was confirmed after the follow-up examination conducted after three months.

The principle of hypnotherapy is difficult to explain, said the lead author of that study, Dr. Magnus Simrén of Sahlgrenska University Hospital in Sweden.

IBS patients were randomized into two groups, one receiving hypnotherapy education and another no therapy at all. Nearly half and above of the patients in the hypnotherapy group improved whereas the patients who received no therapy didn’t improved.
'"/>




Related medicine news :

1. Australian Scientists Silence Cancer Gene
2. Silence Can Be Heard
3. Commonplace Sugar Compound Silences Seizures
4. Intervention Needed to Break Silence on Reproductive Health
5. A ‘Fit’ of Laughter Silenced by an Unusual Surgey
6. Comfort home for mentally depressed
7. Comfortably Obese And Reluctant To Get Fit
8. Comfort Level, Maximum in Ethnically Diverse Schools
9. Soccer Fans Seek Comfort From Alcohol
10. New Reflux Disease Technology More Comfortable, Not More Effective
11. Digestive acid production dependent on newly found hormone
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners is ... sequencing and genomics experience, as Vice President of North American Capital Sales at ... for leading the sales team in the commercialization of the HTG EdgeSeq system and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... 2016 Bracket , a leading clinical trial ... clinical outcomes platform, Bracket eCOA (SM) 6.0, at the ... – 30, 2016 in Philadelphia , Pennsylvania.  ... Assessment product of its kind to fully integrate with RTSM, ... eCOA 6.0 is a flexible platform for electronic clinical outcomes ...
Breaking Medicine Technology: